These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28111300)

  • 1. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results.
    Gilling P; Anderson P; Tan A
    J Urol; 2017 Jun; 197(6):1565-1572. PubMed ID: 28111300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    J Urol; 2018 May; 199(5):1252-1261. PubMed ID: 29360529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
    Lim Ng K; Barber N
    Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Roehrborn C
    Urology; 2019 Mar; 125():169-173. PubMed ID: 30552937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Early Results.
    Yassaie O; Silverman JA; Gilling PJ
    Curr Urol Rep; 2017 Oct; 18(12):91. PubMed ID: 29046995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results.
    Bhojani N; Bidair M; Zorn KC; Trainer A; Arther A; Kramolowsky E; Doumanian L; Elterman D; Kaufman RP; Lingeman J; Krambeck A; Eure G; Badlani G; Plante M; Uchio E; Gin G; Goldenberg L; Paterson R; So A; Humphreys M; Kaplan S; Motola J; Desai M; Roehrborn C
    Urology; 2019 Jul; 129():1-7. PubMed ID: 31059728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes.
    Whiting D; Ng KL; Barber N
    World J Urol; 2021 Aug; 39(8):3019-3024. PubMed ID: 33392647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
    Bhojani N; Bidair M; Kramolowsky E; Desai M; Doumanian L; Zorn KC; Elterman D; Kaufman RP; Eure G; Badlani G; Plante M; Uchio E; Gin G; Paterson R; So A; Roehrborn C; Motola J; Kaplan S; Humphreys M
    J Urol; 2023 Jul; 210(1):143-153. PubMed ID: 37115632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
    Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
    BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia.
    Faber K; de Abreu AL; Ramos P; Aljuri N; Mantri S; Gill I; Ukimura O; Desai M
    J Endourol; 2015 Jan; 29(1):63-9. PubMed ID: 25000418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
    Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Zorn KC; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Goldenberg L; Elterman D; Desai M; Lingeman J; Roehrborn C; Bhojani N
    BJU Int; 2020 Jan; 125(1):112-122. PubMed ID: 31599044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waterjet Ablation Therapy for Treating Benign Prostatic Obstruction in Patients with Small- to Medium-size Glands: 12-month Results of the First French Aquablation Clinical Registry.
    Misrai V; Rijo E; Zorn KC; Barry-Delongchamps N; Descazeaud A
    Eur Urol; 2019 Nov; 76(5):667-675. PubMed ID: 31281024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results.
    Desai M; Bidair M; Bhojani N; Trainer A; Arther A; Kramolowsky E; Doumanian L; Elterman D; Kaufman RP; Lingeman J; Krambeck A; Eure G; Badlani G; Plante M; Uchio E; Gin G; Goldenberg L; Paterson R; So A; Humphreys MR; Roehrborn CG; Kaplan S; Motola J; Zorn KC
    Can J Urol; 2020 Apr; 27(2):10147-10153. PubMed ID: 32333733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic Outcomes After Aquablation.
    Pimentel MA; Yassaie O; Gilling P
    Urology; 2019 Apr; 126():165-170. PubMed ID: 30721737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic review.
    Suarez-Ibarrola R; Bach T; Hein S; Cocci A; Russo GI; Herrmann TRW; Gratzke C; Miernik A
    World J Urol; 2020 May; 38(5):1147-1163. PubMed ID: 31559476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.